191 related articles for article (PubMed ID: 18499211)
61. Assessment of CD4+ and CD8+ IFN-gamma producing cells by ELISPOT in naïve and FIV-infected cats.
Sirriyah J; Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Nov; 102(1-2):77-84. PubMed ID: 15451617
[TBL] [Abstract][Full Text] [Related]
62. Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections.
Novak JM; Crawford PC; Kolenda-Roberts HM; Johnson CM; Mergia A
Virus Res; 2007 Dec; 130(1-2):110-20. PubMed ID: 17644204
[TBL] [Abstract][Full Text] [Related]
63. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
Leutenegger CM; Boretti FS; Mislin CN; Flynn JN; Schroff M; Habel A; Junghans C; Koenig-Merediz SA; Sigrist B; Aubert A; Pedersen NC; Wittig B; Lutz H
J Virol; 2000 Nov; 74(22):10447-57. PubMed ID: 11044089
[TBL] [Abstract][Full Text] [Related]
64. Molecular characteristics of malignant lymphomas in cats naturally infected with feline immunodeficiency virus.
Endo Y; Cho KW; Nishigaki K; Momoi Y; Nishimura Y; Mizuno T; Goto Y; Watari T; Tsujimoto H; Hasegawa A
Vet Immunol Immunopathol; 1997 Jul; 57(3-4):153-67. PubMed ID: 9261955
[TBL] [Abstract][Full Text] [Related]
65. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
Huang C; Conlee D; Gill M; Chu HJ
J Feline Med Surg; 2010 Jun; 12(6):451-7. PubMed ID: 20167521
[TBL] [Abstract][Full Text] [Related]
66. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus.
Prospéro-García O; Herold N; Phillips TR; Elder JH; Bloom FE; Henriksen SJ
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12947-51. PubMed ID: 7809152
[TBL] [Abstract][Full Text] [Related]
67. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
[TBL] [Abstract][Full Text] [Related]
68. Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii.
Levy JK; Ritchey JW; Rottman JB; Davidson MG; Liang YH; Jordan HL; Tompkins WA; Tompkins MB
J Infect Dis; 1998 Aug; 178(2):503-11. PubMed ID: 9697733
[TBL] [Abstract][Full Text] [Related]
69. An experimental study of primary feline immunodeficiency virus infection in cats and a historical comparison to acute simian and human immunodeficiency virus diseases.
Dua N; Reubel G; Moore PF; Higgins J; Pedersen NC
Vet Immunol Immunopathol; 1994 Nov; 43(4):337-55. PubMed ID: 7856070
[TBL] [Abstract][Full Text] [Related]
70. Neurophysiologic and immunologic abnormalities associated with feline immunodeficiency virus molecular clone FIV-PPR DNA inoculation.
Phipps AJ; Hayes KA; Buck WR; Podell M; Mathes LE
J Acquir Immune Defic Syndr; 2000 Jan; 23(1):8-16. PubMed ID: 10708051
[TBL] [Abstract][Full Text] [Related]
71. In vivo lymphocyte tropism of feline immunodeficiency virus.
English RV; Johnson CM; Gebhard DH; Tompkins MB
J Virol; 1993 Sep; 67(9):5175-86. PubMed ID: 7688819
[TBL] [Abstract][Full Text] [Related]
72. Altered cell tropism and cytopathicity of feline immunodeficiency viruses in two different feline CD4-positive, CD8-negative cell lines.
Tokunaga K; Nishino Y; Oikawa H; Ishihara C; Mikami T; Ikuta K
J Virol; 1992 Jun; 66(6):3893-8. PubMed ID: 1374812
[TBL] [Abstract][Full Text] [Related]
73. Serologic reactivity using conserved envelope epitopes in feline lentivirus-infected felids.
Kania SA; Kennedy MA; Potgieter LN
J Vet Diagn Invest; 1997 Apr; 9(2):125-9. PubMed ID: 9211229
[TBL] [Abstract][Full Text] [Related]
74. Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset.
Willett BJ; Hosie MJ; Callanan JJ; Neil JC; Jarrett O
Immunology; 1993 Jan; 78(1):1-6. PubMed ID: 8094707
[TBL] [Abstract][Full Text] [Related]
75. Infections of feline leukemia virus and feline immunodeficiency virus.
Miyazawa T
Front Biosci; 2002 Feb; 7():d504-18. PubMed ID: 11815291
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
Broche-Pierre S; Richardson J; Moraillon A; Sonigo P
J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
[TBL] [Abstract][Full Text] [Related]
77. Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats.
Woo JC; Dean GA; Pedersen NC; Moore PF
J Virol; 1997 Nov; 71(11):8632-41. PubMed ID: 9343221
[TBL] [Abstract][Full Text] [Related]
78. Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.
Nag M; De Paris K; E Fogle J
Viruses; 2018 Apr; 10(5):. PubMed ID: 29710792
[TBL] [Abstract][Full Text] [Related]
79. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
[TBL] [Abstract][Full Text] [Related]
80. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.
Richardson J; Moraillon A; Baud S; Cuisinier AM; Sonigo P; Pancino G
J Virol; 1997 Dec; 71(12):9640-9. PubMed ID: 9371628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
